Table 2.
Characteristics of the patients with active CHB
| Group 1 (n: 24) F0-F1 | Group 2 (n: 40) F2-F4 | P value | |
|---|---|---|---|
| Age (Years) | 40.2 (9.7) | 47.9 (14.0) | 0.142 |
| Sex (M/F) | 11/13 | 22/18 | 0.986 |
| Duration of the disease, mean, years (SD) | 5.8 (5.0) | 7.1 (5.8) | 0.280 |
| Bilirubin, mg/dl (SD) | 0.8 (0.5) | 1.0 (0.6) | 0.054 |
| Albumin, gr/dl (SD) | 4.2 (0.3) | 4.2 (0.4) | 0.895 |
| AST, IU/ml (SD) | 33.2 (21.5) | 54.9 (50.0) | 0.013 |
| ALT, IU/ml (SD) | 43.5 (38.5) | 74.3 (75.7) | 0.029 |
| INR | 0.97 (0.07) | 1.00 (0.08) | 0.185 |
| Platelet Count, /mm3, (SD) | 209.000 (61.000) | 186.000 (57.000) | 0.028 |
| HBV-DNA, IU/ml, (SD) | 1.324.451 (3.804.374) | 2.931.757 (6.595.720) | 0.003 |
| HBeAg negativity, n (%) | 23 (95.8) | 34 (85.0) | 0.185 |
| TPO, pg/ml (SD) | 459.8 (235.7) | 568.9 (433.7) | 0.367 |